Columbus Circle Investors’s AtriCure ATRC Stock Holding History

Columbus Circle Investors’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-104,179	Closed	-$2.04M	–	275
2016 Q4	$2.04M	Sell	104,179 -59,538	-36%	-$1.08M	0.03%	215
2016 Q3	$2.59M	Buy	163,717 +48,807	+42%	+$750K	0.03%	225
2016 Q2	$1.62M	Sell	114,910 -493,305	-81%	-$7.52M	0.02%	216
2016 Q1	$10.2M	Sell	608,215 -94,667	-13%	-$1.67M	0.09%	177
2015 Q4	$15.8M	Sell	702,882 -285,491	-29%	-$5.88M	0.13%	159
2015 Q3	$21.7M	Sell	988,373 -12,319	-1%	-$308K	0.18%	116
2015 Q2	$24.7M	Buy	1,000,692 +764,052	+323%	+$17.1M	0.17%	145
2015 Q1	$4.85M	Buy	236,640 +84,010	+55%	+$1.63M	0.03%	239
2014 Q4	$3.05M	Sell	152,630 -12,378	-8%	-$212K	0.02%	238
2014 Q3	$2.43M	Buy	165,008 +116,192	+238%	+$1.85M	0.02%	221
2014 Q2	$897K	Buy	+48,816	New	+$812K	0.01%	264

Other funds holding ATRC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HEC

Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Columbus Circle Investors's ATRC Position: Q1 2017 in Review

Columbus Circle Investors sold out of AtriCure (ATRC) in Q1 2017, closing a stake of 104,179 shares — an estimated $2.04M sold.

Columbus Circle Investors first reported a position in ATRC in Q2 2014 and held it in 11 quarters. The position peaked at $24.7M in Q2 2015. 99 funds tracked by Wall St. Rank hold ATRC as of Q1 2017.

Columbus Circle Investors reported no remaining AtriCure position as of Q1 2017 after selling out during the quarter.
Columbus Circle Investors sold 104,179 AtriCure shares in Q1 2017, an estimated $2.04M.
Columbus Circle Investors first reported a position in AtriCure in Q2 2014 and held it in 11 quarters.
Columbus Circle Investors's AtriCure position peaked at $24.7M in Q2 2015.
99 funds tracked by Wall St. Rank held AtriCure as of Q1 2017.

Based on Columbus Circle Investors's 13F filing for Q1 2017, filed 20 Apr 2017.